H.B. Fuller to launch new bio-compatible adhesive for medical applications
Swiftmelt 1515-I meets performance requirements and secures skin attachment
Swiftmelt 1515-I meets performance requirements and secures skin attachment
The company is preparing a detailed response to the observations, which will be submitted to the USFDA within the stipulated timelines.
Palbociclib has a unique mechanism of action which helps in delaying disease progression when co-administered with hormonal therapies
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
The JUST 100 is the only ranking that recognizes companies doing right by all their stakeholders as defined by the American public.
NDM disorders are a group of rare, inherited neuromuscular disorders with an estimated prevalence of 1 case per 100,000 inhabitants in Spain, and are characterized by the inability to relax muscles following voluntary contraction (myotonia)
The objective of this system is to shift the focus of measuring performance of hospitals from volume of services provided to value of healthcare services
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
Subscribe To Our Newsletter & Stay Updated